Sherwood | Hims & Hers, at a crossroads, wants to be the Netflix of healthcare

The generic drug maker started with cheeky ads selling knockoff Viagra. Now it’s trying to fend off big drugmakers and navigate a critical government ruling to defend a high-growth line of revenue.

Jay Ritter comments on how Hims’ SPAC has impacted its business. 

Read more in this story from Sherwood.